ArticleJournal of multidisciplinary healthcare2026
Prognostic Value of QT and QTc Interval Dispersion in Acute Pulmonary Embolism: A Retrospective Single-Center Study.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute pulmonary embolism (PE) carries substantial mortality risk, yet readily available electrocardiographic markers of ventricular repolarisation heterogeneity remain underutilised in prognostication. This study evaluated the prognostic value of QT dispersion (QTd) and corrected QT dispersion (QTcd) for predicting 30-day mortality in patients with acute PE. Methods: This single-centre, retrospective observational study enrolled 143 consecutive adult patients with CT-angiography-confirmed acute PE presenting to the emergency department between January 2023 and November 2024. PE severity was stratified per 2019 ESC guidelines. Standard 12-lead ECGs obtained at admission, prior to any PE-directed treatment, were analysed by a single blinded observer. The primary outcome was 30-day all-cause mortality. Independent predictors were identified by multivariable logistic regression, and optimal cut-off values were determined by ROC curve analysis. Results: The 30-day mortality rate was 32.2% (n=46/143). The mean age was 71.0 ± 14.3 years; 13.3% of patients were haemodynamically unstable and 20.3% had active malignancy. Non-survivors exhibited significantly greater QTd (60.2 vs 49.3 ms) and QTcd (80.6 vs 63.1 ms) than survivors (both p<0.001). On multivariable analysis, QTcd remained an independent predictor of mortality (OR 1.09 per ms, 95% CI 1.05-1.13; p=0.001), alongside malignancy (OR 5.05), altered mental status (OR 6.10), mean arterial pressure (OR 0.97 per mmHg), and CT-derived left ventricular diameter (OR 0.92 per mm). ROC analysis identified cut-off values of QTd ≥56 ms (AUC 0.812, sensitivity 72%, specificity 83%) and QTcd ≥67 ms (AUC 0.829, sensitivity 87%, specificity 67%, negative predictive value 92%). Conclusion: QTcd is an independent predictor of 30-day mortality in acute PE and provides clinically useful discrimination across all ESC risk strata. The cut-off values identified may complement established risk scores in emergency prognostication; prospective multicentre validation is required before broader clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.